Jeffrey T. L. Smith,Leon F. Garcia-Martinez,Andrew L. Feldhaus
申请号：
US14672392
公开号：
US09957321B2
申请日:
2015.03.30
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention is directed to therapeutic methods using IL-6 antagonists such as anti-IL-6 antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat mucositis (e.g., oral mucositis) including persons on a treatment regimen with a drug or chemotherapy and/or radiation for cancer (e.g., head and neck cancer) that is associated with increased risk of mucositis, including oral mucositis.
